PRESS RELEASES

INDIGO Biosciences & Bertin Pharma Sign European Distribution Agreement

November 15, 2016

INDIGO Biosciences, the recognized industry-leader in Nuclear Receptor research, and Bertin Pharma have announced the completion of a European distribution agreement. Over 40 product references for studying nuclear receptors are now available for European researchers doing their work in drug discovery and toxicology. These innovative tools are used for profiling compounds in research areas such as metabolic disorders, cardiovascular disease, cancer, obesity, and even endocrinology. These all-inclusive, cell-based, and robust kits reduce time, cost, and risk in the drug discovery process by producing easy-to-analyze, accurate results in a fraction of the time of most other kits available.

Bertin Pharma is one of the major European players for the supply of reagents and assay kits dedicated to research and development for the pharmaceutical, cosmetic, and food industries. Bertin Pharma has marketed biological reagent ranges for over 25 years. Its long R&D experience combined with its international distributor channels enable Bertin Pharma to deliver life sciences tools on time and to support customers throughout their experimentation.

With the addition of INDIGO’s portfolio of Nuclear Receptor Assay kits, Bertin Pharma completes it existing ranges of biomarker assays applied to expertise areas including metabolic syndrome, hypertension, and oncology.

“It has been a real honor to be introduced to Fred and his company, and we rapidly found a lot of complementary aspects of our businesses. The Nuclear Receptor Assay range perfectly fit with our customers’ needs, and will empower our commercial activity.” Patrick Vitaux, Bioreagent Department Manager, Bertin Pharma

“We are pleased to have reached an agreement with Bertin Pharma to expand our distribution network in Europe. We look forward to working with Patrick and his team to bring INDIGO’s assay portfolio to their customers throughout the region.” Fred Marroni, CEO, INDIGO Biosciences

About INDIGO Biosciences, Inc.
INDIGO Biosciences has established itself as an industry-leading provider of both products and services focused on nuclear receptors. INDIGO offers both screening services and assay kits for the pharmaceutical, biotechnology, agri-business, nutriceutical industries, as well as government research agencies and academic researchers.

INDIGO Hires Scott Youells, M.Sc. as Director of Sales

November 14, 2016

State College, PA (November 14, 2016) INDIGO Biosciences is pleased to announce that Scott Youells, M.Sc. has joined INDIGO Biosciences as Director of Sales. Scott comes to INDIGO with more than 15 years of biotech experience, having spent 10 years in a major research laboratory and 6 years in technical sales. His experience in pharmaceutical research, development synthesis, and screening techniques are of critical importance in supporting INDIGO customers.

 
Prior to joining INDIGO, Scott served as Director of Technical Sales in the Pharmaceutical and Petroleum industries. He provided hardware and software solutions to many Fortune 500 companies. These solutions in automated workflows resulted in saving millions of dollars in developmental cost and through process improvements. 
 
“Scott’s proven track record and industry experiences enabled him to become a recognized partner to many customers. His combination of laboratory and sales experience make him an ideal match for INDIGO as it builds its sales team,” says Fred L. Marroni, President and CEO.
 
Scott’s education includes a BS and MS in Chemistry, numerous awards, two patents, and research publications. Please join us in welcoming Scott to the INDIGO Team.  He can be reached at scott@indigobiosciences.com or 484-797-2803.
 

About INDIGO Biosciences, Inc.
INDIGO Biosciences has established itself as an industry-leading provider of both products and services focused on nuclear receptors. INDIGO offers both screening services and assay kits for the pharmaceutical, biotechnology, agribusiness, and nutraceutical industries, as well as government research agencies and academic researchers.
 

kWantera to Form Technology Alliance with GE Renewable Energy

November 01, 2016

kWantera, a Pittsburgh-based start-up and General Electric Company (GE), through its GE Renewable Energy business, today announced a technology alliance to offer kWantera’s energy trading solution to complement GE’s Digital Wind Farm offering. GE Renewable Energy is developing a partner network and engaging the start-up ecosystem to enhance its Digital Wind Farm and other digital products on its Predix* platform.

Sanjeev Addala, Chief Digital Officer, GE Renewable Energy, said,“Working with kWantera is part of GE Renewable Energy’s strategy of exploring innovative digital technologies to strengthen our product offerings.”

This alliance will enable both kWantera and GE Renewable Energy to co-develop digital solutions that allow renewable energy customers to better manage operational risk and scheduling decisions, thereby enhancing revenue from their asset base.

kWantera CEO, Kyle O'Connor, said, "We are excited to partner with GE Renewable Energy to bring kWantera's energy market enhancement technology to wind operators across the U.S.”

kWantera is a Pittsburgh, PA-based company that uses leading technology and predictive analytics to build software tools for companies that buy, sell, or consume energy in markets across North America. Founded in 2012, kWantera serves energy suppliers, manufacturers, the commercial sector, utility operators, and educational institutions. GE Ventures is also an investor in kWantera.

Moody Aldrich Partners Completes Acquisition of kWantix, an Electricity Trading Hedge Fund

October 31, 2016

Marblehead, MA (October 31, 2016)   Moody Aldrich Partners (“MAP”) today announced that it has acquired substantially all of the assets of Pittsburgh based kWantix Trading, LLC and kWantix Trading Advisors, LLC.   In addition, it has entered into a long-term technology licensing agreement with kWantera, Inc. – a Pittsburgh based, power market decision intelligence firm.   With the closing of the deal, Dr. Kaiyu Shen, principal trader at kWantix, joins Moody Aldrich.   The business will continue to operate under the kWantix brand.  

 

“The kWantix trading strategy is a unique quantitative addition to our platform,” stated Eli Kent, Managing Partner of Moody Aldrich Partners, “its proven technology provides us with the foundation to develop an exceptional power trading business.”   

 

kWantix was founded as a subsidiary of kWantera in 2014.  kWantera utilizes advanced data science and predictive analytics technologies to forecast energy markets and to develop customized insights and intelligence for its customers.  Since January 2015, kWantix has used this technology to trade power in a hedge fund structure. 

 

“Our continuing relationship with kWantix and MAP will ensure the fund has access to the latest technology and market intelligence available,” said Kyle O’Connor, CEO of kWantera. “We are excited to see kWantix succeed under MAP’s leadership; it’s a great home for the technology and the team.”   

 

The initial development of the kWantix trading strategy was backed by kWantera and venture capital firms Allied Growth Strategies & Management, LLC, Rusheen Capital Partners and High Sierra Partners, LLC, all of whom will have a continuing relationship with kWantix.  

 

For additional information, please contact:

Eli Kent at Moody Aldrich Partners, LLC, (781) 639-7054, ekent@moodyaldrich.com                            

 

About Moody Aldrich Partners:

Formed in 1988, Moody Aldrich Partners is a privately held asset management company that creates strategic partnerships and business ventures with teams of experienced, successful investors. MAP, a registered investment advisor, is a multi-strategy asset management platform that nurtures and develops investment strategies to meet the needs of institutional and individual investors. The firm leverages its long history of providing investment advisory services to identify and develop quality businesses.

 

About kWantera:

kWantera is a Pittsburgh, PA based company that uses leading-edge technology and predictive analytics to build tools for companies that buy, sell, or consume energy in markets across North America. Founded in 2012, kWantera serves energy suppliers, manufacturers, the commercial sector, utility operators, and educational institutions. To learn more: www.kWantera.com.www.LinkedIn.com/company/Kwantera

 

 

Eli Kent

Managing Partner

Moody Aldrich Partners, LLC

Harvest Funds Management, LLC

p 781.639.7054

c 617.283.9324

 

The information (and any attachments) transmitted is confidential and is intended only for the person or entity to which it is addressed. This information may contain confidential, proprietary, and/or material information that is protected by one or more legally recognized privileges. Any review, retransmission, dissemination, disclosure, or other use of, or of taking any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this transmission in error, please contact the sender and delete this message from all computers and networks without saving it in any manner. Since the confidentiality of Internet e-mail cannot be assured, please do not send confidential information (non-public client or firm information) to others or us. All e-mail sent to or from this address is subject to monitoring, review, archival and disclosure by someone other than the recipient.

INDIGO Announces upcyte® Product Agreement

July 19, 2016

INDIGO Biosciences, the recognized industry-leader in Nuclear Receptor research, and upcyte® technologies GmbH announced completion of a distribution Partnership.  upcyte® technologies GmbH, based in Hampburg-Eppendorf, Germany, is a life science company specializing in controlled, scalable propagation and standardization of human primary cell products. The upcyte® Hepatocytes will be used as a part of INDIGO’s in vitro toxicology platform. This agreement meets the demand for predictive liver toxicity models, necessary due to the high attrition rate of drugs found to cause liver damage following entry into the market.
 
upcyte® technology allows controlled proliferation beyond the typical life span of primary cells without either immortalization or loss of differentiation properties. Utilizing upcyte® human liver cells, INDIGO has completed break-through developments in optimization, decreasing donor-to-donor variability while maintaining many Phase I and Phase II enzyme activities, making these cells more comparable to primary hepatocytes. The virtually unlimited availability of differentiated cells and their long viability period gives upcyte® hepatocytes an advantage over other commonly used cells.
 
Utilizing this unique platform, INDIGO’s services lab can examine your compound’s potential to cause liver toxicity through metabolic activation or by induction of drug metabolism enzymes. upcyte® hepatocytes contain equivalent activity of several cytochrome P450s when compared to human hepatocytes, making the examination of metabolism-dependent toxicity biologically relevant. As with primary human hepatocytes, the induction response is donor-dependent; therefore, upcyte® hepatocytes offer a panel of different donors with a range of induction responses, allowing for greater end-stage predictability. In addition, INDIGO is able to strengthen and quantify changes in the expression of target genes regulated by PXR, CAR, AhR, LXRs, LRH-1, PPARs, and Nrf2.
 
“There is an increasing demand to develop more predictive models for liver toxicity,” says Dr. Jack Vanden Heuvel, INDIGO’s Chief Scientific Officer. “Hepatotoxicity remains a major reason for drug withdrawal from pharmaceutical development and clinical use. These cells offer a very attractive model to predict hepatotoxicity caused by drugs and chemicals of environmental concern.”
 
About INDIGO Biosciences, Inc.
INDIGO Biosciences was founded in 2005 in State College, Pennsylvania, and has established itself as an industry-leading provider of both products and services focused on nuclear receptors. INDIGO offers both screening services and assay kits for the pharmaceutical, biotechnology, agri-business, and nutriceutical industries, as well as government research agencies and academic researchers.

Entrepreneurial Alchemy

Please join us for no-charge events to meet and socialize with ex-pats in your area originally from Westmoreland, Indiana, Cambria, Blair, Somerset and Bedford counties. The idea is to share food and drinks at a bar/restaurant in your area. You’ll have the chance to meet each other as well as have a chance to discover the exciting new economic development projects and entrepreneurial spirit growing back in our part of Western Pennsylvania.
Save the date for the following events.
D.C. area residents: Meet us at Tortoise and Hare in Arlington, VA on Thursday, October 1 at 6:30 p.m. with the Steelers game to follow.
Harrisburg area residents: Meet us at Firehouse Restaurant in Harrisburg on Monday, October 12 at 6:30 p.m. with the Steelers game to follow.
Pittsburgh area residents: Meet us at the Allegheny HYP Club in Pittsburgh on Tuesday, November 10 at 5:30 p.m.
We have been working as Entrepreneurial Alchemy--a group of successful business, community, academic, and non-profit leaders in our region, with the support from Commonwealth of Pennsylvania, to help develop a “regional” alumni network to help catalyze relationships with successful people, both inside and outside of the region. The goal is to help facilitate mutual professional, business, entrepreneurial, and community relationships with one another, as well as potential options for mentoring, partnerships, investments, or buying/selling in the region. We also are interested in providing ongoing information about the state of the region and major issues of interest.
On a separate note, we have been collaborating with a regional group to increase investment capital into entrepreneurship within the community. You will hear more about this exciting effort, called Allegheny Innovation Capital, from fund managers Bob Delach and Don Belt, and well as community representative Mike Hruska from Problem Solutions, Inc.
There is no pressure or obligation. We simply want to get like-minded people interested in connecting with each other now in areas like Harrisburg/Pittsburgh/Washington, D.C., as well as potentially with “back home” in some constructive way. Joining us will be Mike Kane, President of the Community Foundation for the Alleghenies.
RSVP for your desired event at your earliest convenience to Marisa Nelson at mnelson@cfalleghenies.org or (814) 536-7741, ext. 114. Please call me with any questions in advance. My cell is (814) 244-7888.
I look forward to meeting you in person and connecting you with one another.
Thank you.

Donald M. Bonk
Director, Entrepreneurial Alchemy, a program of the Community Foundation for the Alleghenies
www.cfalleghenies.org
Good Future Innovation, LLC, Principal

INDIGO/Cayman Press Release

State College, PA (February 20, 2014) – INDIGO Biosciences, Inc. today announced it has entered into a distribution agreement with Cayman Chemical Company. Cayman will be promoting and distributing INDIGO’s nuclear receptor assay kits and screening services worldwide. This agreement will position INDIGO to attract more customers, increase their market share and sell its products and services on a global basis. 

INDIGO Biosciences is the only contract research services company focused exclusively on nuclear receptor screening, offering a comprehensive menu of nuclear receptor screening services as well as nonhuman nuclear receptor assays, functional assays and custom assay development. 

In addition to their on-site contract screening services, INDIGO Biosciences brings their nuclear receptor expertise directly into their client’s lab with easy-to-use assay kits. Each kit includes reporter cells, assay plates and all reagents for both 96 and 384 well formats. Their assay products feature engineered reporter cells prepared using INDIGO’s CryoMite™ process. Once thawed, cells are ready for immediate use and typically present >95% viability. Test compounds may be screened for agonist or antagonist activities against human nuclear receptors expressed within healthy, dividing mammalian cells.

“We are very excited to work with Cayman Chemical,” said Fred Marroni, CEO, of INDIGO Biosciences. “Teaming up with Cayman Chemical will allow us to expand market awareness and service our customers on a global basis.” 

“INDIGO Biosciences is a great partner and this agreement supports our mission of supplying scientists worldwide with the research tools necessary for advancing human and animal health. Our real commitment to life science researchers is to offer the highest quality products with affordable pricing,” said Dr. Kirk Maxey, President & CEO, of Cayman Chemical. 

About INDIGO Biosciences
INDIGO Biosciences, Inc. was founded in 2005 in State College, PA. It remains a privately held biosciences company offering products and services focused on nuclear receptors to the Pharmaceutical, Biotechnology, Environmental and Neutricutical market. INDIGO provides high-quality, confidential screening services and assay kits for drug discovery and toxicology research. For more information visit their website at www.indigobiosciences.com.

About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Cayman specializes in assay kits for the measurement of hormones and bio-markers. In addition, Cayman offers a broad range of specialty biochemicals used as research reagents and qualified standards. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic. Cayman employs approximately 300 people worldwide.

CHESAPEAKE BAY ROASTING COMPANY ACQUIRES THE

August 18, 2011

CHESAPEAKE BAY ROASTING COMPANY ACQUIRES THE OPERATIONS OF CALLAO COFFEE
Doubles customer base and further expands into northern and central Virginia

CROFTON, MD – Chesapeake Bay Roasting Company, one of the fastest-growing specialty coffee roasters in the mid-Atlantic region, announced today the acquisition of Callao Coffee based in Luray, Virginia. Callao serves more than 150 premier coffee shops, restaurants and food service providers across northern and central Virginia as well as clients across the country.

“Chesapeake Bay Roasting Company set out six years ago to be the most environmentally friendly coffee you could buy with a focus on supporting our ‘local’ community,” said CEO Chris Paladino. ”We restructured the company and raised more than $1.2 million to build out these key initiatives. Today we’re excited to combine the two companies and look forward to expanding our community support throughout the entire Chesapeake Bay Watershed area.”

“While researching CBRC Coffee, we were particularly excited by the H2O Initiative,” said Callao president Don Konz. The H2O Initiative is a community outreach program through which Chesapeake Bay Roasting Company and its customers take a proactive role in the restoration and protection of the watershed, through funding (2% of sales), education, volunteerism and enjoyment of the watershed environment.

The current ownership, management and customer service staff of Callao will be joining the Chesapeake Bay Roasting Company team to ensure that customers receive the same quality and service for which Callao has become known. “Together we believe we can be the premier local coffee company in the region – combining top product quality, customer service and a focus on the environment that no other company comes close to matching, with a well capitalized structure that allows us to invest in our customers and the success of their businesses,” said Paladino.

About Chesapeake Bay Roasting Company
Chesapeake Bay Roasting Company serves more than 300 food service clients and can be found in more than 60 grocery and specialty markets including select Whole Foods, Wegmans, MOMs Organic Markets, Roots and other independent retailers, and coming soon to more than 30 Giant and Safeway stores.

Chesapeake Bay Roasting Company purchases premium grade beans from the world’s best growing regions and estates for our organic and fair trade coffees, signature blends, all natural Swiss water decafs and single origins.

We roast the beans in our Sirocco roaster, a specially designed hybrid that uses 78% less energy than traditional roasters. Named the “single most green roaster in the world” by Roast Magazine, only a few are in use throughout the country. Less energy also means less emissions. The Sirocco reduces them by 80% and keeps an average of more than 400,000 lbs. of C02 and 1,750,000 lbs. of nitrogen from being released into the atmosphere each year.

Chesapeake Bay Roasting Company packages our retail products in a steel can – the number one sustainable packaging material. Our package is 100% recyclable and reusable as opposed to non-recyclable, non-compostable bags, and ensures our coffee reaches our customer in perfect freshness. Plus, we made our package larger (13.75 ounces instead of only 10 or 12 ounces) and give our customers more coffee with each purchase. 

Chesapeake Bay Roasting Company purchases 100% wind power through Constellation Energy’s renewable energy program. 

Reducing our negative impact on the planet by drastically cutting energy use and emissions and using sustainable and recyclable products wasn’t enough for us. Chesapeake Bay Roasting Company has also taken positive steps to improve the health of the Bay and surrounding communities. We created the “H2O Initiative” as a proactive means to do that and dedicate 2% of our coffee sales to organizations in communities throughout the Bay watershed that work to protect and preserve the Bay and its tributaries and watershed, and we promote education, volunteerism and the enjoyment of the Bay.

To learn more, visit us at www.CBRCcoffee.com

Local technology company announces management hires

June 15, 2011

Pittsburgh, PA – MobileFusion, Inc. is pleased to announce the addition of two members to their management team. Ken Durrett has been hired as the new Chief Financial Officer and Bruce Smith joins the team as Vice President of Sales. 

“We are excited about this new direction” said Mark DeSantis, President of MobileFusion. “We are looking forward to the experience that Ken and Bruce bring to the MobileFusion team.”

MobileFusion assists industry, research laboratories, universities, and other businesses where real-time analysis of power usage, power quality and related costs are crucial. Founded in 2006, MobileFusion utilizes a powerful proprietary advanced computing and machine learning-based software platform called SmartPQM that draws data from the customer’s current power infrastructure. MobileFusion works with several strategic partners including among them, Eaton Corporation, a leading provider of smart meters.

Ken Durrett began his career at Price Waterhouse and has over 25 years of executive level financial experience. Ken previously served as President and VP Finance for World Kitchen as well as Chief Financial Officer for both American Outpost and ServiStar. Ken is currently a partner in a national firm which provides CFO services to small to midsize business in a variety of industries. He has a B.S. in accounting from Central Washington University.

Bruce Smith comes to MobileFusion from Achieving Sales Results, a sales consulting company, where he helped small companies such as RedZone Robotics, Clark Testing and Apangea Learning realize substantial sales growth. He began his career with IBM Sales after earning a BA from Albright College in Reading, Pa. Bruce has held sales and executive sales management positions at a variety of firms, including BT North America, Vanstar, Metamor, Paradigm Solutions and Inacom. Bruce has also served as Vice President of Sales & Marketing for Westinghouse Communications. 

“This is a significant development for MobileFusion” said Don Belt, Managing Partner of Allied Growth Strategies Management, the opportunity fund supporting MobileFusion. “These hires not only enhance daily performance for MobileFusion but also make the company more attractive to our Opportunity Fund investors.”

Allied Growth Strategies & Management (AGSM) is a private equity firm that seeks investment and support opportunities for small businesses which demonstrate technology, vision, and excellence in their management team. (www.agsm.biz)

AGSM private equity fund announces investment in Mobile Fusion

May 25, 2011

State College, PA – Allied Growth Strategies & Management, LLC (AGSM) of State College is announcing the expansion of their investment holdings to include MobileFusion, Inc. of Pittsburgh, Pennsylvania. AGSM recently provided $340,000 Bridge Loan to recapitalize the operation and is preparing for raising the first major “A” round for approximately $3.0 million of capital to be used to grow the business from a sales and marketing, expand operational capacity, and institute a R&D initiative. 

“We believe that MobileFusion is an outstanding addition to our portfolio” said Don Belt, Managing Partner of Allied Growth Strategies Management. “We continue to focus our efforts in partnering with cutting edge technology organizations with outstanding management. We are very optimistic about the future of MobileFusion based on the positive reaction received from several prospective customers provided by AGSM.”
MobileFusion, Inc. is a real-time data analytics company currently meeting the power health needs of large organizations across the US. Their growing customer list includes Fortune 100 industrial and processing firms, universities, data service companies and the U.S. military. 

“The challenge our customer’s face every day is the need to consume no more or no less power than required to meet their own daily needs while also maintaining a high level of power quality” said Mark DeSantis, President of MobileFusion. 

MobileFusion, founded in 2006, utilizes a powerful proprietary advanced computing and machine learning-based software platform called SmartPQM that draws data from the customer’s current power infrastructure. SmartPQM is a subscription-based service and provides actionable information to those responsible for managing the organization’s power system – continuously, automatically and in real-time – in whatever form is most convenient for the consumer. MobileFusion works with several strategic partners including among them, Eaton Corporation, a leading provider of smart meters.

“The combination of power optimization and power quality is what is meant by good power ‘health’ and we do it with data” said Abhishek Sharma, Vice President of Technology for Mobile Fusion.

Find out more about MobileFusion, Inc. at www.mobilefusioninc.com.

Chesapeake Bay Roasting Company Closes $1.2 Million Equity Round Company positioned for further growth across the Bay watershed

December 14, 2011

Crofton, MD – Chesapeake Bay Roasting Company, the east coast’s most environmentally friendly coffee company, closed a $1.2 million equity investment to provide the “fuel” for growth throughout the Bay watershed region. Chris Paladino of Silver Spring, Maryland saw an opportunity with the company this past spring and signed on as CEO to lead the transformation of the business from a small local roaster into a regional brand.

“For the last five years we have put our hearts and souls into creating the finest quality, most eco-friendly coffees possible,” said Tom Erber, founding partners, master roaster and coffee connoisseur. 

Several local and regional investors signed on to the company’s growth plans. Allied Growth Strategies & Management, based in State College, Pennsylvania, was an early believer. “Our team focuses on great management teams with great products and brands,” said AGSM partner Don Belt. “Chesapeake Bay Roasting Company has all the components of a successful company – a terrific product with loyal customers, a brand that is connected to its community, and a management team that can keep the growth going.”

Another local investor, Sterling Crockett, has built his share of successful businesses and saw something unique in the Chesapeake Bay Roasting Company team. “Quality product and a solid plan are important – but people are what make a business succeed. This company has brought together a fantastic team that you just can’t help but believe in.” Sterling’s eye for great teams has helped him build Sterling Construction of Rockville, Maryland and R4 Incorporated with offices in New Jersey, Maryland, Afghanistan and multiple other locations, and has led to his skills being recognized by election as chairman of the Montgomery County Chamber of Commerce and the recipient of several regional and national business awards.

Geoff Greble, Coffee Category Manager at Wegmans Supermarkets commenting about the first time he saw the CBRC brand on retail shelves – “The black label and tall can just stands out from all the others and the graphics are outstanding. Geoff went on further to say, “These products are kitchen countertop ready”.

Pedro Matamoros, renowned chef at 8407 Kitchen Bar in Silver Spring, and his partner Nancy Hart have been using Chesapeake Bay Roasting Company coffees since day one. “Nancy and I have long careers in the restaurant business and we have never had so many customers ask us who makes our great coffee.”

About Chesapeake Bay Roasting Company

Chesapeake Bay Roasting Company purchases premium grade beans from the world’s best growing regions and estates for our organic and fair trade coffees, signature blends, all natural Swiss water decafs and single origins.

We roast the beans in our Sirocco roaster, a specially designed hybrid that uses 78% less energy than traditional roasters. Named the “single most green roaster in the world” by Roast Magazine, only a few are in use throughout the United. Less energy also means less emissions. The Sirocco keeps an average of more than 400,000 lbs. of C02 and 1,750,000 lbs. of nitrogen from being released into the atmosphere each year.

Chesapeake Bay Roasting Company packages our retail products in a steel can – the number one sustainable package – and use recycled paper labels with soy based inks. Our package is 100% recyclable and reusable, and ensures our coffee reaches our customer in perfect freshness. Our container gives our customer MORE coffee – 13.75 ounces instead of only 10 or 12 ounces in a non-recyclable, non-compostable bag. 

Chesapeake Bay Roasting Company purchases 100% wind power through Constellation Energy’s renewable energy program. Reducing our negative impact on the planet by drastically cutting energy use and emissions and using sustainable and recyclable products wasn’t enough for us. 

Cheseapeake Bay Roasting Company has also taken positive steps to improve the health of the Bay and surrounding communities. We created the “H2O Initiative” as a proactive means to do that. We dedicate 2% of our coffee sales (not profits) to organizations in communities throughout the Bay region that work to protect and preserve the Bay and its tributaries and watershed.

To learn more, visit  http://www.CBRCcoffee.com

Contact:
Chris Paladino, CEO
(410) 454-0102 x730
(301) 910-6199 cell

Private equity firm continues to expand investment holdings. (INDIGO Biosciences)

March 15, 2011

State College, PA – Allied Growth Strategies Management (AGSM) of State College is announcing the expansion of their investment holdings to include Indigo Biosciences, Inc. of State College. AGSM is in the process of raising $3.5 million of capital to be used to grow the business from a sales and marketing perspective. 

“Indigo Biosciences, Inc. is an excellent example of the innovation and cutting edge technology that is defining our portfolio” said Don Belt, Managing Partner, AGSM. “We are excited to be a part of assisting Dean and the team at INDIGO with advancing their growth and development.”

Indigo Biosciences, Inc. – The Nuclear Receptor Company is the leading provider of Nuclear Receptor Assay kits and screening services in the biopharmaceutical industry. Founded in 2005, Indigo Biosciences, Inc. has grown from a small custom screening company for drug discovery and active ingredient determination to selling products in North America, Europe, and Asia through a network of leading distributors worldwide. 

Nuclear receptors are one class of drug targets which assist in the discovery, development and pre-clinical processes used in the biopharmaceutical industry to bring a new drug to market. Once a receptor or gene associated with a disease is identified, hundreds of thousands to millions of compounds are screened to determine which of those compounds interact with that target. INDIGO’s screening services and Frozen Single-Use Assay products give the user the ability to easily test for potential efficacy and to understand potential risks for toxicity or unwanted side-effects in the development of new biopharmaceutical products. INDIGO’s proprietary cryo-preservation process - CryoMite™ allows INDIGO to ship assay products all over the world. Markets for INDIGO products include biotech, pharmaceutical, and Contract Research Organizations (CROs) as well as academic and government researchers studying nuclear receptors, with a tertiary markets in the nutritional and chemical industry. INDIGO’s products and services increase the accuracy and decrease the cost, time and risks associated with the development of a new biopharmaceutical products for companies such as Johnson and Johnson, GlaxoSmithKline, etc.
“On behalf of the team at INDIGO, I am eager to collaborate with the team at AGSM” said H. Dean Bunnell, CEO of Indigo Biosciences, Inc. “Our cutting edge technology and product support for the biopharmaceutical industry has incredible potential for growth and expansion. “
Find out more about Indigo Biosciences, Inc. – The Nuclear Receptor Company by visiting the website at

www.indigobiosciences.com

AGSM, LLC Announces Venture Capital Investment in Prototype Productions, Inc.

November 09, 2010

State College, PA - Allied Growth Strategies Management, LLC. (AGSM) has closed on an investment in Prototype Productions Inc (PPI). The investment, in the amount of $7,900,000, will fund PPI’s new venture unit – Prototype Productions Inc. Venture Holdings (PPIVH). 

Donald C. Belt, AGSM - Managing Partner, stated – Although the private equity firm was more than five years old, it was first time AGSM had generated external capital through the recruitment of accredited investors in central and western Pennsylvania. Approximately 50 high profile businessmen have invested in the new AGSM Opportunity Fund. AGSM will focus on equity recapitalizations and buyouts of small, privately held companies with revenues up to $20 million. The primary focus of the private equity fund will be on businesses with significant rapid growth potential. These businesses will create value based on their technology, vision, and skills of their management team.

PPI was the perfect first portfolio company for the new private equity fund. “PPI is experiencing unprecedented revenue and contract growth. We made the decision to fund a new ventures effort with AGSM to fully develop and exploit our company’s intellectual property,” said Joe V. Travez, PPI’s President and CEO. “PPI has been awarded eight federal government Small Business Innovative Research Grants over the last 48 months, and we felt partnering with the experienced executives of AGSM was the best process to fully develop our new technologies.”
PPIVH – Three technologies 

The new ventures unit will house three initial technologies and will be managed by Carl J. Wallace who is presently acting as PPI’s Chief Financial Officer. “PPIVH will fulfill PPI’s corporate mission in the commercialization of the unique and innovative product line. We expect to expand on the company’s extensive commercial and government relationships to sell and market these technologies, “said Mr. Wallace. Donald C. Belt, Managing Director stated – “AGSM partnered with the PPI management team to create a unique capital structure to fund the commercialization of the current and future PPI technologies.”

AGSM, LLC is a private equity firm located in State College, PA. AGSM’s target investment area includes the region represented by Central Pennsylvania, Pittsburgh, New York City, Philadelphia, Baltimore, and Washington DC. / Founded in 1991, PPI is a national leader in design, engineering and manufacturing of unique products for the Federal government and commercial markets.
For more information: 

AGSM Contact – Donald C. Belt, (571.220.9885), dbelt@agsm.biz
PPI Contact – Bryan Ramos, (703.858.011), bramos@protoprod.com

Please reload

2016 AGSM LLC, All rights Reserved.